Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Journal of Hepatology
|
August 4, 2025
Phosphatidylethanol in steatotic liver disease
Nikolaj Torp, Mads Israelsen, Maja Thiele, et al.
Annals of Hepatology
|
July 3, 2025
Targeted albumin infusions in hospitalized patients with cirrhosis receiving terlipressin: A post-hoc analysis of ATTIRE
Nikolaj Torp, Louise China, Mads Israelsen, et al.
BMJ Open
|
February 14, 2024
Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial
Nikolaj Torp, Mads Israelsen, Minneke Coenraad, et al.
JHEP Reports : Innovation in Hepatology
|
August 17, 2021
Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication
Mads Israelsen, Min Kim, Tommi Suvitaival, et al.
JHEP Reports : Innovation in Hepatology
|
October 25, 2021
Corrigendum to 'Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis' [JHEP Reports 3 (2021) 100287]
Nikolaj Torp, Mads Israelsen, Bjørn Madsen, et al.
JHEP Reports : Innovation in Hepatology
|
May 27, 2021
Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis
Nikolaj Torp, Mads Israelsen, Bjørn Madsen, et al.
Annals of Hepatology
|
June 12, 2026
Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event
Lorenz Balcars, Adrian Wunderbaldinger, Lucie Simonis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 30, 2021
Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO-C3)
Nikolaj Torp, Mads Israelsen, Mette J Nielsen, et al.
JHEP Reports : Innovation in Hepatology
|
February 25, 2026
Fibrosis activity <i>vs</i>. disease stage: Complementary and independent predictors of outcomes in alcohol-related liver disease
Stine Johansen, Mads Israelsen, Katrine Holtz Thorhauge, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 15, 2023
Validation of scores of PRO-C3 to predict liver-related events in alcohol-related liver disease
Stine Johansen, Mads Israelsen, Ida F Villesen, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Journal of Hepatology
|
August 4, 2025
Phosphatidylethanol in steatotic liver disease
Nikolaj Torp, Mads Israelsen, Maja Thiele, et al.
Annals of Hepatology
|
July 3, 2025
Targeted albumin infusions in hospitalized patients with cirrhosis receiving terlipressin: A post-hoc analysis of ATTIRE
Nikolaj Torp, Louise China, Mads Israelsen, et al.
BMJ Open
|
February 14, 2024
Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial
Nikolaj Torp, Mads Israelsen, Minneke Coenraad, et al.
JHEP Reports : Innovation in Hepatology
|
August 17, 2021
Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication
Mads Israelsen, Min Kim, Tommi Suvitaival, et al.
JHEP Reports : Innovation in Hepatology
|
October 25, 2021
Corrigendum to 'Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis' [JHEP Reports 3 (2021) 100287]
Nikolaj Torp, Mads Israelsen, Bjørn Madsen, et al.
JHEP Reports : Innovation in Hepatology
|
May 27, 2021
Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis
Nikolaj Torp, Mads Israelsen, Bjørn Madsen, et al.
Annals of Hepatology
|
June 12, 2026
Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event
Lorenz Balcars, Adrian Wunderbaldinger, Lucie Simonis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 30, 2021
Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO-C3)
Nikolaj Torp, Mads Israelsen, Mette J Nielsen, et al.
JHEP Reports : Innovation in Hepatology
|
February 25, 2026
Fibrosis activity <i>vs</i>. disease stage: Complementary and independent predictors of outcomes in alcohol-related liver disease
Stine Johansen, Mads Israelsen, Katrine Holtz Thorhauge, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 15, 2023
Validation of scores of PRO-C3 to predict liver-related events in alcohol-related liver disease
Stine Johansen, Mads Israelsen, Ida F Villesen, et al.
Page
of 5